Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine
Stacie J Fairley, Shree R Singh, Abebayehu N Yilma, Alain B Waffo, Praseetha Subbarayan, Saurabh Dixit, Murtada A Taha, Chino D Cambridge, Vida A Dennis Center for NanoBiotechnology Research, Alabama State University, Montgomery, AL, USA Abstract: We recently demonstrated by in vitro experiments tha...
Guardado en:
Autores principales: | Fairley SJ, Singh SR, Yilma AN, Waffo AB, Subbarayan P, Dixit S, Taha MA, Cambridge CD, Dennis VA |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/02123a29b6334a68a0c501e58a5ba193 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Formulation, characterization, and expression of a recombinant MOMP Chlamydia trachomatis DNA vaccine encapsulated in chitosan nanoparticles
por: Cambridge CD, et al.
Publicado: (2013) -
Anti-inflammatory effects of silver-polyvinyl pyrrolidone (Ag-PVP) nanoparticles in mouse macrophages infected with live Chlamydia trachomatis
por: Yilma AN, et al.
Publicado: (2013) -
A Chlamydia trachomatis VD1-MOMP vaccine elicits cross-neutralizing and protective antibodies against C/C-related complex serovars
por: Anja Weinreich Olsen, et al.
Publicado: (2021) -
THE PREVALENCE OF CHLAMYDIA TRACHOMATIS INFECTION IN SAINT-PETERSBURG
por: L. B. Kulyashova, et al.
Publicado: (2014) -
CHLAMYDIA TRACHOMATIS: TRANSMISION VERTICAL CON MEMBRANAS INTEGRAS
por: Valdés R,Enrique, et al.
Publicado: (2002)